BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 28479091)

  • 21. Modeling the Embrace of a Mutator: APOBEC Selection of Nucleic Acid Ligands.
    Salter JD; Smith HC
    Trends Biochem Sci; 2018 Aug; 43(8):606-622. PubMed ID: 29803538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA deamination in immunity: AID in the context of its APOBEC relatives.
    Conticello SG; Langlois MA; Yang Z; Neuberger MS
    Adv Immunol; 2007; 94():37-73. PubMed ID: 17560271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity.
    Swanton C; McGranahan N; Starrett GJ; Harris RS
    Cancer Discov; 2015 Jul; 5(7):704-12. PubMed ID: 26091828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advantages and disadvantages of cytidine deamination.
    Cascalho M
    J Immunol; 2004 Jun; 172(11):6513-8. PubMed ID: 15153462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical Characterization of APOBEC3H Variants: Implications for Their HIV-1 Restriction Activity and mC Modification.
    Gu J; Chen Q; Xiao X; Ito F; Wolfe A; Chen XS
    J Mol Biol; 2016 Nov; 428(23):4626-4638. PubMed ID: 27534815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. APOBEC-2, a cardiac- and skeletal muscle-specific member of the cytidine deaminase supergene family.
    Liao W; Hong SH; Chan BH; Rudolph FB; Clark SC; Chan L
    Biochem Biophys Res Commun; 1999 Jul; 260(2):398-404. PubMed ID: 10403781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. APOBEC-mediated editing of viral RNA.
    Bishop KN; Holmes RK; Sheehy AM; Malim MH
    Science; 2004 Jul; 305(5684):645. PubMed ID: 15286366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. APOBEC3A is a prominent cytidine deaminase in breast cancer.
    Cortez LM; Brown AL; Dennis MA; Collins CD; Brown AJ; Mitchell D; Mertz TM; Roberts SA
    PLoS Genet; 2019 Dec; 15(12):e1008545. PubMed ID: 31841499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases.
    Conticello SG; Thomas CJ; Petersen-Mahrt SK; Neuberger MS
    Mol Biol Evol; 2005 Feb; 22(2):367-77. PubMed ID: 15496550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficient deamination of 5-methylcytidine and 5-substituted cytidine residues in DNA by human APOBEC3A cytidine deaminase.
    Suspène R; Aynaud MM; Vartanian JP; Wain-Hobson S
    PLoS One; 2013; 8(6):e63461. PubMed ID: 23840298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical analysis of hypermutation by the deoxycytidine deaminase APOBEC3A.
    Love RP; Xu H; Chelico L
    J Biol Chem; 2012 Aug; 287(36):30812-22. PubMed ID: 22822074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. APOBEC: A molecular driver in cervical cancer pathogenesis.
    Revathidevi S; Murugan AK; Nakaoka H; Inoue I; Munirajan AK
    Cancer Lett; 2021 Jan; 496():104-116. PubMed ID: 33038491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. APOBEC3s: DNA-editing human cytidine deaminases.
    Silvas TV; Schiffer CA
    Protein Sci; 2019 Sep; 28(9):1552-1566. PubMed ID: 31241202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Creating RNA Specific C-to-U Editase from APOBEC3A by Separation of Its Activities on DNA and RNA Substrates.
    Tang G; Xie B; Hong X; Qin H; Wang J; Huang H; Hao P; Li X
    ACS Synth Biol; 2021 May; 10(5):1106-1115. PubMed ID: 33938211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DRONE: Direct Tracking of DNA Cytidine Deamination and Other DNA Modifying Activities.
    Sasaki T; Kudalkar SN; Bertoletti N; Anderson KS
    Anal Chem; 2018 Oct; 90(20):11735-11740. PubMed ID: 30256094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strand-biased cytosine deamination at the replication fork causes cytosine to thymine mutations in Escherichia coli.
    Bhagwat AS; Hao W; Townes JP; Lee H; Tang H; Foster PL
    Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2176-81. PubMed ID: 26839411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome-wide mapping of regions preferentially targeted by the human DNA-cytosine deaminase APOBEC3A using uracil-DNA pulldown and sequencing.
    Sakhtemani R; Senevirathne V; Stewart J; Perera MLW; Pique-Regi R; Lawrence MS; Bhagwat AS
    J Biol Chem; 2019 Oct; 294(41):15037-15051. PubMed ID: 31431505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications.
    Holden LG; Prochnow C; Chang YP; Bransteitter R; Chelico L; Sen U; Stevens RC; Goodman MF; Chen XS
    Nature; 2008 Nov; 456(7218):121-4. PubMed ID: 18849968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytidine deamination and resistance to retroviral infection: towards a structural understanding of the APOBEC proteins.
    Huthoff H; Malim MH
    Virology; 2005 Apr; 334(2):147-53. PubMed ID: 15780864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nucleic acid determinants for selective deamination of DNA over RNA by activation-induced deaminase.
    Nabel CS; Lee JW; Wang LC; Kohli RM
    Proc Natl Acad Sci U S A; 2013 Aug; 110(35):14225-30. PubMed ID: 23942124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.